Cipla Ltd.
Research Cipla Ltd. (CIPLA.NS) on Bullrun: market cap INR 1.07T, P/E 31.8, dividend yield 1.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCIPLA.NS
- ExchangeNSE
- CountryIndia
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyINR
- Market capINR 1.07T
- P/E31.8
- Dividend yield1.0%
- Financial periodQ2 2026
- RevenueINR 70.77B
- Net incomeINR 7.89B
- Gross margin62.3%
Valuation Snapshot
latest market cap is INR 1.07T; P/E is 31.8; dividend yield is 1.0%.
Peer valuation comparison
Latest P/E is 31.78x versus a Healthcare sector median of 21.74x (46.1% above).
Latest dividend yield is 0.98% versus a Healthcare sector median of 2.4% (59.2% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | INR 1.07T | 31.8 | 1.0% | 13 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 13 INR, yield 1.0%.
About Cipla Ltd.
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Cipla Ltd.'s market cap?
Cipla Ltd.'s market capitalization is INR 1.07T.
What is Cipla Ltd.'s P/E ratio?
Cipla Ltd.'s price-to-earnings (P/E) ratio is 31.8.
Does Cipla Ltd. pay a dividend?
Cipla Ltd. has a dividend yield of 1.0%.
What does Cipla Ltd. do?
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.